Lifecore Biomedical, Inc. De (LFCR) Non-Current Deferred Tax Liability (2011 - 2024)

Lifecore Biomedical's Non-Current Deferred Tax Liability history runs 14 years deep, the most recent figure standing at $552000.0 for Q4 2024.

• In Q4 2024, Non-Current Deferred Tax Liability rose 32.69% year-over-year to $552000.0; the TTM figure through Nov 2024 stood at $552000.0 (up 32.69% YoY), while the FY2024 annual figure was $543000.0, up 42.89% from the prior year.
• Non-Current Deferred Tax Liability was $552000.0 for Q4 2024 at Lifecore Biomedical, up from $443000.0 in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $41.0 million in Q2 2020 to a low of $10000.0 in Q4 2022.
• Historically, Non-Current Deferred Tax Liability has averaged $5.0 million across 5 years, with a median of $701500.0 in 2022.
• The sharpest annual moves came in 2022 and 2023: Non-Current Deferred Tax Liability plunged 99.17% in 2022, then jumped 4060.0% in 2023.
• A 5-year view of Non-Current Deferred Tax Liability shows it stood at $6.6 million in 2020, then slumped by 81.89% to $1.2 million in 2021, then slumped by 99.17% to $10000.0 in 2022, then surged by 4060.0% to $416000.0 in 2023, then soared by 32.69% to $552000.0 in 2024.
• The last three Non-Current Deferred Tax Liability figures came in at $552000.0 (Q4 2024), $443000.0 (Q3 2024), and $543000.0 (Q2 2024), per Business Quant data.